TrialInternational journal of clinical oncology2016

Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.

Kazuo Tamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.